1 Min Read
NEW YORK, Oct 3 (Reuters) - Sarepta Therapeutics Inc : * Jumps 129.2 percent to $34.35 premarket after Duchenne Muscular Dystrophy drug eteplirsen trial results
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.